Gene · 25937
Papers2,228
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,228
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An extremely rare case of pulmonary epithelioid hemangioendothelioma. | Thorac Cancer | 2023 | 37488675 | PubTator, text mining | PubMed |
| Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target. | Front Oncol | 2023 | 37476371 | PubTator, text mining | PubMed |
| Tumor matrix stiffness provides fertile soil for cancer stem cells. | Cancer Cell Int | 2023 | 37468874 | PubTator, text mining | PubMed |
| Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma. | Melanoma Res | 2023 | 37467061 | PubTator, text mining | PubMed |
| TGF-β based risk model to predict the prognosis and immune features in glioblastoma. | Front Neurol | 2023 | 37456651 | PubTator, text mining | PubMed |
| Dissecting the Methylomes of EGFR-Amplified Glioblastoma Reveals Altered DNA Replication and Packaging, and Chromatin and Gene Silencing Pathways. | Cancers (Basel) | 2023 | 37444635 | PubTator, text mining | PubMed |
| The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment. | Cancers (Basel) | 2023 | 37444578 | PubTator, text mining | PubMed |
| The Tumor Suppressor DAB2IP Is Regulated by Cell Contact and Contributes to YAP/TAZ Inhibition in Confluent Cells. | Cancers (Basel) | 2023 | 37444489 | PubTator, text mining | PubMed |
| Prognostic Factors in Epithelioid Hemangioendothelioma: Analysis of a Nationwide Molecularly/Immunohistochemically Confirmed Cohort of 57 Cases. | Cancers (Basel) | 2023 | 37444414 | PubTator, text mining | PubMed |
| Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome. | Front Genet | 2023 | 37434949 | PubTator, text mining | PubMed |
| Identification of angiogenesis-related genes signature for predicting survival and its regulatory network in glioblastoma. | Cancer Med | 2023 | 37434432 | PubTator, text mining | PubMed |
| Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS. | BMC Cancer | 2023 | 37400763 | PubTator, text mining | PubMed |
| Inducible Protein Degradation as a Strategy to Identify Phosphoprotein Phosphatase 6 Substrates in RAS-Mutant Colorectal Cancer Cells. | Mol Cell Proteomics | 2023 | 37392812 | PubTator, text mining | PubMed |
| AR activates YAP/TAZ differentially in prostate cancer. | Life Sci Alliance | 2023 | 37385752 | PubTator, text mining | PubMed |
| Pharmacogenomic Analyses Implicate B Cell Developmental Status and MKL1 as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy. | Cells | 2023 | 37371044 | PubTator, text mining | PubMed |
| Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications. | J Exp Clin Cancer Res | 2023 | 37370109 | PubTator, text mining | PubMed |
| Inhibition of TAZ impairs the migration ability of melanoma cells. | Open Life Sci | 2023 | 37360787 | PubTator, text mining | PubMed |
| Epithelioid Hemangioendothelioma Presenting as Necrotizing Pneumonia. | Cureus | 2023 | 37351241 | PubTator, text mining | PubMed |
| Insights into recent findings and clinical application of YAP and TAZ in cancer. | Nat Rev Cancer | 2023 | 37308716 | PubTator, text mining | PubMed |
| High VEGF Concentrations Accelerate Human Trabecular Meshwork Fibrosis in a TAZ-Dependent Manner. | Int J Mol Sci | 2023 | 37298577 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25937/papers?page=14